Previous 10 | Next 10 |
home / stock / cvs / cvs articles
On CNBC’s "Mad Money Lightning Round," Jim Cramer said CVS Health Corporation (NYSE: CVS) is a retailer that has a healthcare bus...
CVS Health Corp (NYSE: CVS) has reportedly decided to remove specific decongestant products from its stores after an advisory by a panel ...
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors said Mondelez International, Inc. (NA...
Walgreens Boots Alliance Inc (NASDAQ: WBA) and CVS Health Corp (NYSE: CVS) CVS pharmacy staff are reportedly planning a na...
CVS Health Corp (NYSE: CVS) shares are trading higher by 2.1% to $72.38 Friday morning. Shares of several healthcare providers are trading higher i...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be u...
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 ...
The Georgia Board of Pharmacy began accepting applications from nearly 120 pharmacies to provide medical marijuana products, making it the first st...
The rising prevalence of obesity and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO) Wegovy and Ozempic is tri...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporat...
CVS Health to hold second quarter 2024 earnings conference call PR Newswire WOONSOCKET, R.I. , July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7 th , 2024, at 8:00 a.m. ET ...
2024-07-03 08:15:00 ET Some beaten-down stocks have significant upside potential and, therefore, present attractive buying opportunities for investors. However, other companies that are failing to keep pace with the market and are likely to keep struggling for a long time aren't worth inves...